MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1001/jamaoto.2016.0937

Медицинская библиотека · JAMA otolaryngology-- head & neck surgery · 2016

National Practice Patterns of Antireflux Medication for Chronic Rhinosinusitis.

Fonseca-Sada Jose Ignacio, Martinez-Mejorada Roberto, Garcia-Gonzalez Gabriel, Lozano-Carrillo Luis Carlos, Valdez-Velez Rodolfo Alfredo, Garcia-Perez Mauricio, Valdes-Flores Everardo

СтатьяПеревод пока не подготовлен

Аннотация

IMPORTANCE

Antireflux medication has been endorsed as a useful adjunctive therapy for chronic rhinosinusitis, but its use remains controversial.

OBJECTIVES

To determine whether chronic rhinosinusitis is associated with administration of proton pump inhibitors, histamine2-receptor antagonists, antacids, or prokinetic agents; whether practice patterns vary according to visit setting; and whether those patterns vary according to the presence or absence of potentially confounding conditions.

DESIGN, SETTING, AND

PARTICIPANTS

A cross-sectional analysis was performed of data from January 1, 2005, to December 31, 2010, from the National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey, which included 590 772 observations representing 7 191 711 480 ambulatory care visits. Univariate, multivariate, and stratified analyses were performed from January 1, 2005, to December 31, 2010.

EXPOSURES: Chronic rhinosinusitis.

MAIN OUTCOMES AND MEASURES: The probability of receiving antireflux medications was the main measured outcome.

RESULTS

Of 7 191 711 480 ambulatory care visits, those for chronic rhinosinusitis were not more likely to result in the administration of proton pump inhibitors (odds ratio, 1.00; 95% CI, 0.62-1.63; P = .99) or antacids and prokinetic agents (odds ratio, 1.24; 95% CI, 0.30-5.10; P = .77). In addition, patients with chronic rhinosinusitis were less likely to receive histamine2-receptor antagonists than were those without chronic rhinosinusitis, even when adjusted for age, sex, race/ethnicity, visit setting, other antireflux agents, and presence or absence of gastroesophageal reflux, laryngopharyngeal reflux, or allergy diagnoses (odds ratio, 0.25; 95% CI, 0.12-0.57; P = .001).

CONCLUSIONS AND RELEVANCE: National practice patterns observed thus far have not favored the use of proton pump inhibitors, histamine2-receptor antagonists, antacids, or prokinetic agents for chronic rhinosinusitis.

Для цитирования: Fonseca-Sada Jose Ignacio, Martinez-Mejorada Roberto, Garcia-Gonzalez Gabriel, Lozano-Carrillo Luis Carlos, Valdez-Velez Rodolfo Alfredo, Garcia-Perez Mauricio, Valdes-Flores Everardo. National Practice Patterns of Antireflux Medication for Chronic Rhinosinusitis.. JAMA otolaryngology-- head & neck surgery. 2016. DOI: 10.1001/jamaoto.2016.0937.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.